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ABSTRACT
Biologically active complexes of Co(II), Ni(II), Cu(II) and Zn(II) with novel ONO, NNO and
SNO donor pyrazinoylhydrazine-derived compounds have been prepared and characterized on the basis of
analytical data and various physicochemical studies. Distorted octahedral structures for all the complexes
have been proposed. The synthesized ligands and their complexes have been screened for their antibacterial
activity against bacterial species Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus and
Klebsiella pneumonae. The activity data show the metal complexes to be more active than the parent free
ligands against one or more bacterial species.
INTRODUCTION
In recent years hydrazines and hydrazones have been actively investigated as donors because of their
interesting biological properties
1-5 and varied ligational behaviour
69 towards different metal ions and
manifestation of novel structural features in co-ordination chemistry. Much work has been done with their
Schiff-base derived pyridine ring system 1. Pyrazine system with an additional nitrogen ring becomes a
weaker base1, but it forms structurally important metal complexesv-9. The present investigation was
undertaken to develop and study a novel variety of interactions of such Schiff-base ligands derived from the
reaction of pyrazinoylhydrazine with furane-2-aldehyde, thiophene-2-aldehyde and pyrrol-2-aldehyde.
16-20 22 23 12 15 Many previous reports and a part of our ongoing research program have indicated the role of
metal ions in increasing the biological activity upon chelation.
X=O: L N N
X=S Lz
X=NH.L3
Figure Structure of the ligand
In continuation to the same in the present studies we have synthesized novel p,razinoylhydrazine derived
tridentate ONO, NNO and SNO donor Schiff-base ligands L=L, L and L (Fig.l) and their metal
complexes having a general formula [(ML2)CI2] where M=Co(II), Ni(II), Cu(II) and Zn(I) and L=2
pyrazinoyl[ 1-(2-furanylmethylene)]hydrazide (L1), 2-pyrazinoyl[1-(2-thienylmethylene)]hydrazide (L2) and 2-
pyrazinoyl[ 1-(2-pyrrolylmethylene)]hydrazide (L3).
The synthesized Schiff-base ligands and their metal complexes have been screened for their possible
antibacterial activity against bacterial strains of Escherichia coli, Pseudomonas aeruginosa, Staphylococcus
aureus and Klebsiella pneumonae The antibacterial activity data of the ligands are shown to be
substantially increased upon chelation against one or more bacterial strains.
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EXPERIMENTAL
Material and Methods
All chemicals and solvents used were of Analar grade. All the metals were used as their metal(II) salts. IR,
H NMR and 3C NMR spectra were recorded on Philips Analytical PU 9800 FTIR and Brucker 250 MHz
instruments. 13C resonances were assigned by the use of ref. 21. UV- Visible spectra were obtained on a
Hitachi U-2000 double-beam spectrophotometer. Conductance of the metal complexes was determined in
DMF on a YSI-32 model conductometer. Magnetic measurements were done on solid complexes using the
Gouy method. Melting points were recorded on a Gallenkamp apparatus and are uncorrected. The
antibacterial studies were carried out with the help of the Department of Pathology, Quaid-e-Azam Medical
College, Bahawalpur, Pakistan.
Preparation of Ligands
2-Pyrazinoyl[ 1-(2-furanylmethylene)hydrazide] (L)
Furan-2-aldehyde (0.8 mL, 0.96 g, 0.01 tool) in absolute ethanol (15 mL) was added to a magnetically
stirred ethanol solution (25 mL) of pyrazinoylhydrazine (0.01 mol). Then 2-3 drops of concentrated sulfuric
acid were added and mixture refluxed for h. This mixture on cooling gave a solid product which was
filtered, washed with ethanol (2x5 mL) then thoroughly with ether and dried. It was then crystallized in
aqueous ethanol (50. %) to give (L l) (0.92 g). The same methodology was adopted for the preparation of
(L2) (0.88 g) and (L) (0.94 g).
Preparation of Metal Complexes
To a hot ethanolic solution (20 mL) of the ligand (0.02 tool) was added an aqueous solution (10 mL) of the
respective metal (II)salt (0.01 mol). The mixture was refluxed for 2 h. The resulting mixture was cooled,
filtered and reduced to nearly half of its volume. This concentrated solution was left ovemight at room
temperature which resulted in the formation of a solid product. The product thus obtained was filtered,
washed with ethanol (2x10 mL) and dried. Crystallization from aqueous ethanol (50 %) gave the desired
complexes (1-12).
Antibacterial Studies
Preparation of Discs.
The ligand/complex (30 (g) in DMF (0.0 lmL) was applied on a paper disc, [prepared from blotting paper (3
mm diameter)] with the help of a micropipette. The discs were left in an incubator for 48 h at 37 C and then
applied on the bacteria grown agar plates.
Preparation of Agar Plates.
Minimal agar was used for the growth of specific bacterial species. For the preparation of agar plates for
Escherichia coli, MacConkey agar (50 g), obtained from Merck Chemical Company, was suspended in
freshly distilled water (1 L). It was allowed to soak for 15 minutes and then boiled on a water bath until the
agar was completely dissolved. The mixture was autoclaved for 15 minutes at 120 C and then poured into
previously washed and sterilized Petri dishes and stored at 40C for inoculation.
,Table Ph,ysical pectral and Anal,ytical Data of the Liands.,
Schiffbase/ M.P. IR Calc (Found %)
Mol. Form.
L
CoHvN402
[215.1]
2
Cl0H7N4OS
[231.1]
L
CIoH8NsO
[214.1]
(C)
192
187
i79
3275, 2915, 2865,
2015, 1945, 1714,
1620, 1350, 1060, 875,
345
3275, 2910, 2865,
2015, 1945, 1714,
1620, 1345, 1060,
875, 345
3275, 2910, 2865,
201,5, 1945, 1714,
1620, 1345, 1060, 877,
345
C H N
55.83 3.25 26.03
(55.8) (3.0) (26.1)
51.96 3.02 24.23
(51.9) (3.3) (24.1)
56.09 3.73 32.69
(56.2) (3.7) (32.8)
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Procedure of Inoculation.
Inoculation was done with the help of a platinum wire loop which was made red hot in a flame, cooled and
then use for the application of bacterial strains.
Application of Discs.
A sterilized forceps was used for the application of paper disc on tlae already inoculated agar plates. When the
discs were applied, they were incubated at 37 C t0r 24 h. he zone of inhibition was then measured (in
diameter) around the disc.
RESULTS AND DISCUSSION
The Schiff-base ligands L , L and L were prepared by a simple condensation reaction. The structural
determination of these ligands was done with the help of IR, IH-NMR, 3C-NMR and microanalytical data
(Tables & 2). The tentative assignment of some of the important infrared bands of ligands are recorded in
Table 1. These bands in spectra of the free ligands show characteristic frequencies at 3275, 1714 and 1620
cm1. These are assigned to v(NH), v(C=O) and v(C=N) stretches respectively.
Table 2
L
+/-H NMR and 3C NMR Ia of the Li
1HNMR ’(lMSO-d6j ’3CNMR (DMSO-d6)
(ppm) (ppm)
L 4.54-4.56 (m, 1H, furanyl), 4.68 (ddl 1H, fur nyl),
5.88 (s, IH, furanyl), 6.13 (s, 1H, azomethine),
7.76-7.78 (m, 2H), 7.91-7.94(m, 1H), 8.34 (s,
1,
’C 104.71 (3), 112.24 (C7), 121.36 (Cs), 123.22
(C4), 124.1 (C6), 126.2 (C2), 129.12 (C8),
137.27 (C9), 152.31 (C=N), 187.38 (C=O).
4.55-4.57 (m, 1H, thienyl)i 4.71 (dd, 1H,
thienyl), 5.86(s, lH, thienyl), 6.15 (s, 1H,
azomethine), 7.74 7.76 (m, 2H), 7.92-7.94 (m,
1H), 8.34 (s, H, NH)
L ’4’.’3L4.55 (m, 1H, pyrrolyl), 4.66 (dd, 1H,
pyrrolyl), 5.85 (s, 1H, pyrrolyl), 6.15 (s, IH,
azomethine), 7.73-7.75 (m, 2H), 7.91-7.93 (m,
1H), 8.33 (s, H, NH), 8.48 (s, H, NH,),
104’6 (C3), i12.21 (C7), 121.18 (Cs), 123.2
(C4), 124.53 (C6), 126.08 (C2), 129.50 (C8),
137.46 (C9), 153.13 (C=N), 186.92 (C=O).
1041 (C3), 112.56 (C7), 121.3 (C5), 123.46
(C4), 124.41 (C6), 126.82 (C2), 129.38 (C8),
137.22 (C9), 153.0 (C=N), 188.27 (C=O).
The H-NMR spectra (Table 2) also display signals assignable to azomethine, amide and other expected ring
13 protons. C-NMR spectra (Table 2) similarly, showed all carbons in their expected region. Also, the
microanalytical data (Table 1) was found to be in agreement with the molecular structures of the title
ligands. All the ligands apparently, contain a number of potential donor groups, which can act as co-
ordination sites for metal chelation. Model studies as illustrated in Fig show that these ligands act as
tridentate and in no case they can exhibit a quadridentate behavior.
IR spectra of the ligands also show well defined v(C=O) and v.qNH) modes and no stretching due to
the presence ofv(OH) frequency in the region at 3360-3420 cm was found which was indicative of
their more probable keto form (A) than the enol form (B). Furthermore, the absence of phenolic proton
v(OH) in H-NMR spectra confirmed keto configuration of the ligands.
All the metal complexes (1-12) were prepared by stoichiometric reactions of the respective metal(II) chlorides
and respective ligands in the molar ratio M:L 1:2. All complexes are air and moisture stable solids. They
are soluble in DMSO, DMF and water and insoluble in other solvents. Molar conductance values of 10
.3 M
solutions of the complexes in DMSO (35-52 ohm cm mol) and water (75-87 ohm cm mol) indicated
24
the complexes to be non-electrolytes, although some solvolysis occurred.
Magnetic Susceptibility
The magnetic measurements (Table 3) for the solid complexes at room temperature are indicative of three
unpaired electrons per Co(II) ion (lae 4.93-5.45 B.M), two unpaired electrons per Ni(II) ion (laeff 2.87-
25 28
3.22 B.M) and one unpaired electron per Cu(II) ion (geff 1.48-1.65 B.M) suggesting octahedral
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geometry for Co(II) and Ni(II) and distorted octahedral geometry for Cu(II) complexes. The Zn(II) complexes
were found to be diamagnetic.
Table 3
No
Ph, Data of Metal Chelates
Metal chelate/ Yied M.P B.M Calc (Found)%
Mol. Formula (%) (C) (teff) C H N
[Co(L)2(C1)2] 79 226-228 4.93
C2oHl4CoNsO4
[560.03]
42.89 2.49 19.99
(42.76) (2.58) (20.13)
2 [Co(L2)2(C1)2] 87 221-222 5.45
C2oHI4CoN8OzS2
[592.03]
40.57 2.36 18’91
(41.08) (2.88) (18.76)
3 [Co(LS)2(CI)2] 75 215-217 5.36
C2oH16CoN 1oO2
[558.03]
43.04 2.86 25.08
(42.85) (2.91) (25.48)
4 [Ni(L’)2(CI)2] 88 230-231 2.87
C2oH14NiNsO4
[560.06]
5 [Ni(L2)2(CI)2] 88 233-235 3.22
C2oH14NiN802S2
[589.76]
6 [Ni(L3)2(CI)2] 75 220.222 3.18
C2oH16NiNIoOz
[558.06]
42.88 2.49 19.99
(42.56) (2.79) (20.24)
40.7 2.36 18.91
(40.96) (2.51) (18.37)
43.04 2.86 25.08
(43.18) (2.77) (25.32)
7 [Cu(L’)2(Cl)2]C2oH,4CuN804 75 238-241 1.48
[564.65]
8 [Cu(L2)2(CI)2] 83 231-233 1.65
C2oH4CuN802S2
[596.65]
42.53 2.47 19.83
(42.64) (2.18) (20.09)
40.25 2.34 18.77
(40.39) (2.51) (18.80)
9 [Cu(L)2(CI)z] 87 228-230 1.56
C2oH6CuNloO2
[584.92]
10 [Zn(L)2(CI)2] 85 218-220 dia
C2oHaZnNsO
[566.49]
11 [Zn(L2)z(Cl)2] 87 211-214 dia
C2oH4ZnN802S2
[598.49]
12 [Zn(L3)2(Cl)2] 88 202-204 dia
C2oHl6ZnNloO2
[564.49]
42.69 2.84 24.88
(42.93) (2.57) (24.78)
42.40 2.47 19.77
(42.76) (2.81) (19.46)
40.13 2.33 18.71
(40.55) (2.61) (18.47)
42.55 3.18 24.80
(42.78) (3.01) (24.93)
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Table 4 and An cal Data of Metal Chelates
’No IR (cm :’) Lmax (cm )
3275 (NI2I), 1714’(C=O), 1615 (C=N), 10 29205, 18352, 8165
(M-O), 360 (N-N)
3275 (NH), 1715 (C=O), 1612 (CLN), 510
(M-O), 365 (N-N)
30265, 19225, 9740
3 3275 (NH), 1715 (C=O), 1615 (C=N), 510’ 31260, 18550, 8595
(M-O), 367 (N-N)
4 3275 (NH), 1’14 (C=O), 1612 (C=N), 510 29671, 19185, 9690
(M-O), 365 (N-N)
5 327’5 (NH), 1715 (C=O), 1615 (C--N), 445 28950, 16220, 9455
(M-S), 365 (N-N)
6 3275 (NH), 1715 (C=O), 1610 (C=N), 450 27375, 17523, 10112
(M-S), 365 (N-N)
7 3275 (NH), 1714 (C=O), 1612 (C=N), 445 28567, 16832, 9875
(M-S), 367 (N-N)
8 3275 (NH), 1715 (C=O), 1610 (C=N), 445
(M-S), 365 (N-N)
27845, 16555, 9742
9 3275 (NH),"’1715 (C=O), 1615 (C=N), 385 13965
(M-N), 365 (N-N)
10 3275 (NH), 1715 (C’=O), 1615 iC’---N), 395’ 15220
(M-N), 367 (N-N)
11 3275 (NH), 1715 (C=O), 1612 (C=N), 390 1486")
(M-N), 365 (N-N)
12 3275 (NH), 1715 (C=O), 1612 (C=N), 388 15111
(M-N), 365 (N-N)
Infrared Spectra
Co-ordination of the ligands with the metal ions was investigated by comparing the infrared spectra of the
free ligands with the spectra of their metal complexes (Table 4). IR spectra of the ligands generally show
bands at 3275 (s, sh), 1714 (s), 1620 (s) and 1000-1060 cm tentatively assigned to VNH, VC--O, VC--N and VN-N
respectively29’3. In their metal complexes, the amide band remains at the same position as in the flee ligand
indicating that keto oxygen adjacent to this amide is not co-ordinated. Upward shift of the VN-N band and
31 32 downward shift of azomethine linkage suggested co-ordination throu.h nitrogen of the azomethine group
(-CH=N-). The pyrazine ring out of plane bending vibration at 345 cm moved to 367 cm indicating that
the ring nitrogen is also involved in co-ordination.
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Moreover, the new bands alpearing in the spectra of the complexes and not observed in the spectra of the
ligands within 510-525 cm, 445-450 cm and 382-395 cm assigned
33’34 to M-O, M-S and M-N modes,
respectively, indicated that the heteroatoms X (O, S or N) are also co-ordinated to the metal(II) ion.
Table 5 Antibacterial Activity Data
Ligand/Chelate M c r
a
L
L
L
10
11
12
++
+/
++++
+/
+++
+++
+++
//
/++
+++
++++
+++
obial
b
+/
+/
++/
+++
/+
++++
++
+++
+++
+++
+/
+++
/+
Spec
c
/+
+++
++++
+++
+++
++++
+/+
+++
//
+++
c e s
d
+/
++++
+++
/+
+++
+/
+++
+/
++++
+/
+++
+/
a-Escherichia coli, b=Pseudomonas aeruginosa,
c=Staphylococcus aureus d=Klebsiella pneumonae
Inhibition zone diameter (mm), +; 6-10, ++; 10-14, +++; 14-18, ++++; 18-22
Electronic Spectra
Electronic spectra of the metal complexes are recorded in Table 4. The spectra of the cobalt chelates show
three bands observed at 8165-9740 cm, 18352-19225 cm and 29205-32265 cm which may be assigned
35 36
to 4Tg 4T2g (F), Tg 4A2g (F) and Tlg 4Ttg (P) transitions, respectively, and are suggestive
-1 -1 ofoctahedral geometry around the cobalt ion. Three bands observed at 9455-10112 cm 16220-17523 cm
and 27375-28950 cm in the spectra of the nickel(II) chelates are due to spin-allowed transitions from 3A2g
T2g (F), A2g --’) Alg (F) and A2g Tg (P), transitions, respectively, in an octahedral
37 a8 environment ’". The copper(II) chelates show only one band around 13965-15220 cm corresponding to
.39 40 :Eg --
:T2g transition, probably due to a distorted octahedral environment
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Based on the magnetic moment and spectral data, it may be tentatively proposed (Fig 2) that all the
complexes possess an octahedral geometry in which all the ligands behaving as tridentate arrange themselves
around the metal ion in such a way that a stable configuration of the metal chelate is attained.
Antibacterial Studies
The title ligands in comparison to their metal complexes were screened against bacterial species Escherichia
coli, Pseudomonas aeruginosa, Staphylococcus aureus and Klebsiella pneumonae and in order to determine
their antibacterial properties. The antibacterial activity was tested at a concentration 30g/0/01 mL in DMF
using paper disc diffusion method as reported earlier4’42.
The results of these studies reported in Table 5 showed that the ligands and all their metal complexes are
biologically active against one or more bacterial species and the metal complexes have been shown to be
more antibacterial than the simple uncomplexed parent ligands.
REFERENCES
2.
3.
4.
5.
6.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
21.
22.
23.
24.
25.
26.
27.
28.
29.
30.
31.
32.
33.
34.
37.
C. Pelizzi, G. Pelizzi and F. Vitali, J. Chem. Soc (Dalton Trans)., 1987, 177.
A. Mangia, C. Pelizzi and G. Pelizzi, Acta. Crystallogr., 1974, 30B: 2146.
C. Pelizzi, G. Pelizzi, G. Predieri and S. Resola, J. Chem. So (Dalton Trans)., 1982, 1349.
M. B. Hursthouse, S. Amarasiri, A. Jayaweera and A. Quick, J. Chem. Soc (DaltonTrans)., 1979, 279.
R. Haran, J. Gairin and G. Commenges, Inorg. Chim. Acta, 1980, 46: 63.
T. B. Murphy, D. K. Johnson, N. J. Rose, A. Aruffo and V. Schomaker, Inorg. Chim. Acta, 1982, 66:
L-67.
E. B. Flescher, D. Jeter and R. Flortan, Inorg. Chem., 1974, 13: 1042.
E. B. Flescher and M. B. Lawson, Inorg. Chem., 1972, 11: 2772.
C. L. Clein, E. D. Stevens, C. J. O’Connor, R. J. Majestes and L. M. Trefonas, Inorg. Chim. Acta,
1983, 70: 151.
R. L. Dutta and M. M. Hossain, J. Sient. Ind. Res., 1985, 44: 635.
A. Albert, R. Goldacre and J. Phillips, J. Chem. Soc., 1948, 2240.
D. R. Williams, "The Metals of Life-The Solution Chemistry of Metal Ions in Biological Systems",
Van Nostrand, London, 1971.
S. Kirschner, Y. K. Wei, D. Francis and J. G. Bergman, J. Med. Chem., 1966, 9: 369.
M. J. Clare, J. D. Heeschele, Bioinorg. Chem., 1973, 2:187.
B. Rosenberg and L. V. Camp, Cancer. Res., 1970, 30:1799.
Z. H. Chohan and A. Rauf, Synth. React. Inorg. Met-Org. Chem., 1996, 26:591.
Z. H. Chohan and A. Rauf, J. Inorg. Biochem., 1992, 46:41.
Z. H. Chohan and S. Kausar, Chem. Pharm. Bull., 1992, 40: 2555.
Z. H. Chohan, M. Praveen and A. Ghaffar, Metal-Based Drugs, 1997, 4: 267.
Z. H. Chohan and S. K. A. Sherazi, Metal-Based Drugs, 1997, 4: 65, 69.
D. H. Williams and I. Fleming, "Spectroscopic Methods in Organic Chemistry", 4th Ed., McGraw
Hill, London, 1989.
Z. H. Chohan and A. Rauf, Metal-Based Drugs, 1996, 3:211.
Z. H. Chohan and H. Pervez, Synth. React. Inorg. Met-Org. Chem.,1993, 23: 1061.
W. J. Geary, Coord. Chem. Rev., 1971, 7:81.
R. H. Niswander, A. K. St Clair, S. R. Edmondson and L. T. Taylor, Inorg. Chem., 1975, 14" 478.
R. C. Stoufer, D. W. Smith, E. A. Clevenger and T. E. Norris, Inorg. Chem., 1966, 5:1167.
M. Kato, H. B. Jonassen and J. C. Fanning, Chem. Rev., 1964, 64, 99.
C. J. Balhausen, "An Introduction to Ligand Field", McGraw Hill, New York, 1962.
K. Burger, I. Ruff and F. Ruff, J. Inorg. Nul. Chem., 1965, 27, 179.
C. Pelizzi and G. Pelizzi, Inorg. Chim. Acta, 1976, 18, 39.
R. C. Aggarwal, N. K. Singh and R. P. Singh, Inorg. Chem., 1981, 20, 2794.
I. Gamo, Bull. Chem. So. Japan, 1961, 34, 1430.
L. J. Bellamy, "The Infrared Spectra of Complex Molecules", 3
rd Ed, Methuen, London, 1966.
K. Nakamoto, "Infrared Spectra of Inorganic and Co-ordination Compounds", J. Wiley, New York, 2
"d
Ed, 1970.
A. D. Liehr, J. Phys. Chem., 1967, 67, 1314.
R. L. Carlin, "Transition Metal Chemistry", Ed. R. L. Carlin, Vol 1, Marcel Decker, New York,
1965.
A. B. P. Lever, "Inorganic Electronic Spectroscopy", Elsevier, Amsterdam, 1984.
273Vol. 5, No. 5, 1998 Studies on Some Biologically Cobalt(II), Copper(II) and Zinc(II) Complexes
with ONO, NNO, andSNO Donor Pyrazinoylhydrazine-derived Ligands
38. D.W. Meek, R. S. Drago and T. S. Piper, Inorg. Chem., 1962, 1,285.
39. W.E. Estes, D. P. Govel, W. E. Halfield and D. J. Hodgson, Inorg. Chem., 1978, 17, 1415.
40. A.B.P. Lever, J. Lewis and R. S. Nyholm, J. Chem. Soc., 1963, 2552.
41. Z.H. Chohan, Chem. Pharm. Bull., 1991, 39, 1578.
42. Z.H. Chohan and S. Kausar, Chem. Pharm. Bull., 1993, 41, 951.
Received" May 28, 1998- Accepted" June 26, 1998-
Received in revised camera-ready format" July 2, 1998
274